Cryoport, Inc. (CYRX) stock
CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3022% above fair value
$20.17+0.43 (+2.18%)
Close on Nov 18, 2026Market cap $1.02BP/E –Yield –
Cryoport revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Cryoport's revenue for the twelve months ending Jun 30, 2026 was $186.45M, up 12.1% year over year. For fiscal 2025 it was $176.18M, up 12.4% from the year before. Over ten years it grew 52.1% a year on average. The highest annual figure on record is $237.28M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $176.18M | +12.4% |
| FY2024 | Dec 31, 2024 | $156.77M | -7.1% |
| FY2023 | Dec 31, 2023 | $168.66M | -28.9% |
| FY2022 | Dec 31, 2022 | $237.28M | +6.6% |
| FY2021 | Dec 31, 2021 | $222.61M | +182.9% |
| FY2020 | Dec 31, 2020 | $78.70M | +131.9% |
| FY2019 | Dec 31, 2019 | $33.94M | +72.9% |
| FY2018 | Dec 31, 2018 | $19.63M | +233.7% |
| FY2016 | Mar 31, 2016 | $5.88M | +49.5% |
| FY2015 | Mar 31, 2015 | $3.94M | +47.9% |
| FY2014 | Mar 31, 2014 | $2.66M | +141.7% |
| FY2013 | Mar 31, 2013 | $1.10M | +98.1% |
| FY2012 | Mar 31, 2012 | $555.64K | +16.9% |
| FY2011 | Mar 31, 2011 | $475.50K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $48.97M | +7.7% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $47.80M | +16.5% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $45.45M | +9.6% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $44.23M | +15.4% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $45.45M | +14.5% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $41.04M | +10.1% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $41.45M | -27.6% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $38.32M | -31.8% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $39.71M | -30.4% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $37.29M | -40.6% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $57.26M | -5.1% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $56.16M | -7.1% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $57.02M | -11.1% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $62.82M | +20.1% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $60.36M | +6.9% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $60.46M | +6.7% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $64.15M | +14.2% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $52.30M | -1.8% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $56.44M | +16.7% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $56.69M | +407.5% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $56.19M | +498.5% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $53.28M | +445.2% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $48.36M | +423.3% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $11.17M | +16.6% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $9.39M | +10.9% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $9.77M | +46.9% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $9.24M | +62.4% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $9.58M | +81.3% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $8.46M | +82.9% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $6.65M | +65.4% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $5.69M | – |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | $5.29M | +262.2% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $4.63M | +222.0% |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | $4.02M | +181.1% |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | $0 | -100.0% |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | $1.46M | +49.6% |
| Q2 FY2016CQ3 2015 | Sep 30, 2015 | $1.44M | – |
| Q1 FY2016CQ2 2015 | Jun 30, 2015 | $1.43M | – |
| Q4 FY2015CQ1 2015 | Mar 31, 2015 | $1.56M | – |
| Q3 FY2015CQ4 2014 | Dec 31, 2014 | $975.00K | – |
See a number that looks wrong?